David Jin
Director of Finance/CFO chez AVENUE THERAPEUTICS, INC.
Fortune : 304 038 $ au 31/03/2024
Profil
David Jin is currently the CFO, CAO & Head of Corporate Development at Fortress Biotech, Inc. He is also the Secretary, Chief Operating & Financial Officer at Avenue Therapeutics, Inc. starting in 2022.
Previously, he worked as the Director-Corporate Development at Sorrento Therapeutics, Inc. and as the Vice President-Healthcare Investment Banking at FBR & Co. Mr. Jin completed his undergraduate degree at Northwestern University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
FORTRESS BIOTECH, INC.
0,83% | 01/04/2024 | 152 019 ( 0,83% ) | 304 038 $ | 31/03/2024 |
| 09/01/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de David Jin
| Sociétés | Poste | Début |
|---|---|---|
| AVENUE THERAPEUTICS, INC. | Director of Finance/CFO | 11/05/2022 |
| FORTRESS BIOTECH, INC. | Director of Finance/CFO | 16/08/2022 |
Anciens postes connus de David Jin
| Sociétés | Poste | Fin |
|---|---|---|
| FBR & CO | Corporate Officer/Principal | - |
| SORRENTO THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formation de David Jin
| Northwestern University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| FORTRESS BIOTECH, INC. | Health Technology |
| SORRENTO THERAPEUTICS, INC. | Health Technology |
| AVENUE THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
FBR & Co.
 FBR & Co. Investment Banks/BrokersFinance FBR & Co. provides investment banking, merger and acquisition advisory, institutional brokerage and research services through its subsidiaries. The company operates through two segments: Capital Markets and Principal Investing. The Capital Markets segment includes investment banking, institutional brokerage and research. It also provides investment banking services, including capital raising and financial advisory services for its corporate issuer clients, and institutional brokerage services including sales, trading, research, and securities lending services to its institutional investor clients. The Principal Investing segment activities consist primarily of investments in merchant banking and other equity investments, investment funds and corporate debt investments. The company was founded in June 2006 and is headquartered in Arlington, VA. | Finance |
